RxDoctor Payments Data

Angela Merlino

Physician Assistant · Irwin, PANPI 1942216080

Payments from drug & device makers

$295in general payments, 2019–2025

Across 11 payments — averaging $26.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Incyte Corporation$99
  • Boston Scientific$60
  • Daiichi Sankyo Inc.$51
  • Otsuka America Pharmaceutical, Inc.$25
  • Mirati Therapeutics, Inc.$21
  • Eisai Inc.$16
  • plus $24 from 2 others

What the payments were for

  • Food & beverage$16456%
  • Education$13144%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$295 in reported general payments places this provider in the 60th percentile of 6,643 physician assistant providers in Pennsylvania.

See all physician assistant providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$54,485
Medicare patients
177
Services billed
3,319

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JakafiRuxolitinib Phosphate23$396,167
CalquenceAcalabrutinib Maleate18$217,497
XareltoRivaroxaban101$96,789
EliquisApixaban55$47,705
Enoxaparin Sodium18$5,699
Anastrozole270$4,528
Hydroxyurea64$1,297
Letrozole68$1,239
Tamoxifen Citrate16$1,037
Prochlorperazine Maleate22$830
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen64$672
ValacyclovirValacyclovir Hcl25$607
Warfarin Sodium11$303
Ondansetron Hcl23$246
Levothyroxine Sodium50$239

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Incyte CorporationJakafi$99$396,16723 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 6,643 physician assistant providers in Pennsylvania.

Other physician assistant in Irwin

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →